berberine has been researched along with Carcinogenesis in 13 studies
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, the effects and the mechanism of BBR on colon cancer were investigated in an azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated carcinogenesis mice model." | 8.12 | Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota. ( Deng, J; Han, L; Li, Y; Shi, J; Wang, H; Yan, Y; Yuan, X; Zhang, H; Zhao, H; Zhao, L; Zhao, Y; Zou, F, 2022) |
| " Berberine can reduce colorectal adenoma recurrence and inhibit colorectal carcinogenesis." | 8.12 | Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. ( Chang, J; Geng, Z; Hao, X; Liu, J; Tan, X; Wang, Z; Yan, S, 2022) |
| "Recent studies have suggested the potency of berberine (BBR) for multiple cancer treatments, including multiple myeloma (MM)." | 8.12 | Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma. ( Fei, J; Gu, C; Huang, G; Li, C; Liu, Y; Su, R; Wang, X; Yang, J; Yin, Z, 2022) |
| "Colorectal carcinogenesis and progression are related to the gut microbiota and the tumor immune microenvironment." | 5.91 | Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula. ( Chen, H; Chen, Y; Cui, Y; Fang, J; Gao, Q; Kang, Z; Li, X; Liu, Q; Qian, Y; Wang, Z; Zhao, L; Zhou, C; Zou, T, 2023) |
| " In this study, the effects and the mechanism of BBR on colon cancer were investigated in an azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated carcinogenesis mice model." | 4.12 | Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota. ( Deng, J; Han, L; Li, Y; Shi, J; Wang, H; Yan, Y; Yuan, X; Zhang, H; Zhao, H; Zhao, L; Zhao, Y; Zou, F, 2022) |
| " Berberine can reduce colorectal adenoma recurrence and inhibit colorectal carcinogenesis." | 4.12 | Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. ( Chang, J; Geng, Z; Hao, X; Liu, J; Tan, X; Wang, Z; Yan, S, 2022) |
| "Recent studies have suggested the potency of berberine (BBR) for multiple cancer treatments, including multiple myeloma (MM)." | 4.12 | Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma. ( Fei, J; Gu, C; Huang, G; Li, C; Liu, Y; Su, R; Wang, X; Yang, J; Yin, Z, 2022) |
| " In the azoxymethane initiated and dextran sulfate sodium (AOM/DSS) promoted colorectal carcinogenesis mouse model, berberine treated mice showed a 60% reduction in tumor number (P = 0." | 3.81 | Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. ( Colburn, NH; Hou, W; Hua, B; Jia, L; Li, W; Lin, H; Matter, MS; Saud, SM; Young, MR, 2015) |
| "Colorectal carcinogenesis and progression are related to the gut microbiota and the tumor immune microenvironment." | 1.91 | Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula. ( Chen, H; Chen, Y; Cui, Y; Fang, J; Gao, Q; Kang, Z; Li, X; Liu, Q; Qian, Y; Wang, Z; Zhao, L; Zhou, C; Zou, T, 2023) |
| "Chronic inflammation is known to promote carcinogenesis; Dicer heterozygous mice are more likely to develop colitis-associated tumors." | 1.56 | Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis. ( Chen, X; Gao, J; He, Q; He, ZW; Jin, Y; Lei, Y; Liu, H; Ou, R; Song, G; Tang, KF; Wang, WY; Wang, Z; Wei, LJ; Wu, X; Xu, Y; Yang, W; Zhang, Z; Zhong, S; Zhou, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 10 (76.92) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JM | 1 |
| Wu, JY | 1 |
| Chen, SH | 1 |
| Chao, WY | 1 |
| Chuang, HH | 1 |
| Kam, KH | 1 |
| Zhao, PW | 1 |
| Li, YZ | 1 |
| Yen, YP | 1 |
| Lee, YR | 1 |
| Deng, J | 1 |
| Zhao, L | 2 |
| Yuan, X | 1 |
| Li, Y | 1 |
| Shi, J | 1 |
| Zhang, H | 1 |
| Zhao, Y | 1 |
| Han, L | 1 |
| Wang, H | 2 |
| Yan, Y | 1 |
| Zhao, H | 1 |
| Zou, F | 1 |
| Chen, H | 3 |
| Ye, C | 2 |
| Cai, B | 1 |
| Zhang, F | 1 |
| Wang, X | 3 |
| Zhang, J | 3 |
| Zhang, Z | 2 |
| Guo, Y | 2 |
| Yao, Q | 2 |
| Yan, S | 1 |
| Chang, J | 1 |
| Hao, X | 1 |
| Liu, J | 1 |
| Tan, X | 1 |
| Geng, Z | 1 |
| Wang, Z | 3 |
| Li, C | 1 |
| Su, R | 1 |
| Huang, G | 1 |
| Liu, Y | 1 |
| Yang, J | 2 |
| Yin, Z | 1 |
| Gu, C | 1 |
| Fei, J | 1 |
| Liu, Q | 2 |
| Tang, J | 1 |
| Chen, S | 1 |
| Hu, S | 1 |
| Shen, C | 1 |
| Xiang, J | 1 |
| Chen, N | 1 |
| Wang, J | 1 |
| Ma, X | 1 |
| Zhang, Y | 1 |
| Zeng, J | 1 |
| Wu, C | 1 |
| Xu, L | 1 |
| Xu, C | 1 |
| Qian, Y | 1 |
| Kang, Z | 1 |
| Zhou, C | 1 |
| Gao, Q | 1 |
| Cui, Y | 1 |
| Li, X | 1 |
| Chen, Y | 1 |
| Zou, T | 1 |
| Fang, J | 1 |
| Wu, X | 1 |
| Chen, X | 1 |
| Liu, H | 1 |
| He, ZW | 1 |
| Wei, LJ | 1 |
| Wang, WY | 1 |
| Zhong, S | 1 |
| He, Q | 1 |
| Ou, R | 1 |
| Gao, J | 1 |
| Lei, Y | 1 |
| Yang, W | 1 |
| Song, G | 1 |
| Jin, Y | 1 |
| Zhou, L | 1 |
| Xu, Y | 1 |
| Tang, KF | 1 |
| Šudomová, M | 1 |
| Berchová-Bímová, K | 1 |
| Marzocco, S | 1 |
| Liskova, A | 1 |
| Kubatka, P | 1 |
| Hassan, STS | 1 |
| Agnarelli, A | 1 |
| Natali, M | 1 |
| Garcia-Gil, M | 1 |
| Pesi, R | 1 |
| Tozzi, MG | 1 |
| Ippolito, C | 1 |
| Bernardini, N | 1 |
| Vignali, R | 1 |
| Batistoni, R | 1 |
| Bianucci, AM | 1 |
| Marracci, S | 1 |
| Li, W | 1 |
| Hua, B | 1 |
| Saud, SM | 1 |
| Lin, H | 1 |
| Hou, W | 1 |
| Matter, MS | 1 |
| Jia, L | 1 |
| Colburn, NH | 1 |
| Young, MR | 1 |
| Chen, L | 1 |
| Zheng, M | 1 |
| Kong, X | 1 |
| Huang, T | 1 |
| Cai, YD | 1 |
2 reviews available for berberine and Carcinogenesis
| Article | Year |
|---|---|
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Topics: Anti-Bacterial Agents; Berberine; Carcinogenesis; Cytokines; Gastritis; Gastritis, Atrophic; Helicob | 2022 |
Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.
Topics: Animals; Antiviral Agents; Berberine; Carcinogenesis; Clinical Trials as Topic; Herpesviridae; Herpe | 2021 |
11 other studies available for berberine and Carcinogenesis
| Article | Year |
|---|---|
9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Berberine; Bromides; Carcinogenesis; Carcinoma, Non-Sm | 2021 |
Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Topics: Animals; Azoxymethane; Berberine; Carcinogenesis; Colitis; Colon; Dextran Sulfate; Disease Models, A | 2022 |
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Topics: Animals; Azoxymethane; Berberine; Carcinogenesis; Colitis; Colon; Dextran Sulfate; Disease Models, A | 2022 |
Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Topics: Animals; Azoxymethane; Berberine; Carcinogenesis; Cell Transformation, Neoplastic; Colitis; Colorect | 2022 |
Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma.
Topics: Animals; Apoptosis; Berberine; Bortezomib; Carcinogenesis; Cell Line, Tumor; Humans; Mice; Molecular | 2022 |
Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Topics: Animals; Berberine; Carcinogenesis; Colorectal Neoplasms; Diet, High-Fat; Gastrointestinal Microbiom | 2023 |
Berberine might block colorectal carcinogenesis by inhibiting the regulation of B-cell function by Veillonella parvula.
Topics: Animals; Berberine; Carcinogenesis; Colorectal Neoplasms; Humans; Tumor Microenvironment; Veillonell | 2023 |
Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis.
Topics: Anastrozole; Animals; Berberine; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; | 2020 |
Cell-specific pattern of berberine pleiotropic effects on different human cell lines.
Topics: Apoptosis; Autophagy; Berberine; Carcinogenesis; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Pr | 2018 |
Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Azoxymethane; Berberine; Carcinogenesis; Caspase | 2015 |
The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.
Topics: Animals; Antineoplastic Agents; Arsenicals; Berberine; Carcinogenesis; Carcinoma, Non-Small-Cell Lun | 2015 |